EFFICACY OF VIMPAT (LACOSAMIDE) TN THE TREATMENT OF DRUG-RESISTANT CRYPTOGENIC FOCAL EPILEPSY WITH FOCAL AUTOMOTOR AND SECONDARILY GENERALIZED SEIZURES (A CLINICAL CASE)
- Authors: Mironov M.B.1, Mukhin K.Y.1, Pylaeva O.A.1
-
Affiliations:
- Институт детской неврологии и эпилепсии имени Святителя Луки, Москва
- Issue: Vol 7, No 2 (2012)
- Pages: 3-12
- Section: AUTHENTIC ARTICLES
- Published: 17.07.2015
- URL: https://rjdn.abvpress.ru/jour/article/view/77
- DOI: https://doi.org/10.17650/2073-8803-2012-7-2-3-12
- ID: 77
Cite item
Full Text
Abstract
Despite the considerable advances of epileptology drug-resistant epilepsies consist about 30% among all forms of epilepsy. A case of successful using of a new antiepileptic drug lacosamide (vimpat) in the treatment of 31 years old patient with the resistant form of cryptogenic focal epilepsy with focal automotor and secondarily generalized seizures is presented. Authors represent the review of the literature devoted to efficacy and tolerability of lacosamide in the treatment of drug-resistant epilepsy.
Keywords
About the authors
M. B. Mironov
Институт детской неврологии и эпилепсии имени Святителя Луки, Москва
Author for correspondence.
Email: fake@neicon.ru
Russian Federation
K. Yu. Mukhin
Институт детской неврологии и эпилепсии имени Святителя Луки, Москва
Email: fake@neicon.ru
Russian Federation
O. A. Pylaeva
Институт детской неврологии и эпилепсии имени Святителя Луки, Москва
Email: fake@neicon.ru
Russian Federation
References
Supplementary files


